SCHEMBL7312374

SCHEMBL7312374

OC1(c2cc3ccccc3s2)c2ccccc2-c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 11/20 0.46
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CHRM5 P08912 1/20 0.44
CHRM1 P11229 1/20 0.44
CHRM3 P20309 1/20 0.44
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
THPO P40225 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CYP2A6 P11509 1/20 0.41
MGLL Q99685 1/20 0.41
PMP22 Q01453 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17533941 0.81 APP (0.47) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL3680020 0.73 SIGMAR1 (0.38) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL20199302 0.72 PDK2 (0.46) CYP2A6MGLL
SCHEMBL21880270 0.71 PDK2 (0.41) TSHR
SCHEMBL23878715 0.70 SIGMAR1 (0.60) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL3673477 0.70 SIGMAR1 (0.44) SIGMAR1CHRM2CHRM4CHRM5CHRM1
SCHEMBL20174704 0.68 PDK2 (0.45) CYP2A6MGLL
SCHEMBL7315923 0.68 PDK2 (0.38) KMT2ANPSR1
SCHEMBL7310523 0.68 PDK2 (0.38)
SCHEMBL7316770 0.67 PDK2 (0.43) SIGMAR1CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001009117-A1 TRICYCLIC COMPOUNDS AS GLYCINE TRANSPORT INHIBITORS ALLELLIX NEUROSCIENCE INC. (US) 2001-02-08 WO disclosed
US-6162824-A NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS ALLELIX NEUROSCIENCE INC. 2000-12-19 US disclosed